Filter
402
Text search:
XDR-TB
Featured
Recommendations
52
New Publications
107
Language
Document type
No document type
308
Studies & Reports
28
Guidelines
27
Situation Updates
12
Manuals
8
Training Material
6
Fact sheets
6
Strategic & Response Plan
5
Resource Platforms
1
Infographics
1
Countries / Regions
Western and Central Europe
44
Eastern Europe
31
South Africa
15
India
14
Namibia
9
Kenya
8
Tanzania
8
Bangladesh
8
Uganda
6
Nepal
6
Germany
6
Ukraine
6
Myanmar / Burma
6
Russia
6
Ethiopia
5
Zambia
5
Global
5
Botswana
4
Latin America and the Carribbean
4
Senegal
3
Ghana
3
Mozambique
3
Colombia
3
Asia
3
Armenia
3
Philippines
2
Malawi
2
Eswatini/ Swaziland
2
Lesotho
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Paraguay
2
Tajikistan
2
Georgia
2
Vietnam
2
Sierra Leone
1
Cambodia
1
Gambia
1
Rwanda
1
Indonesia
1
Peru
1
Madagascar
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Africa
1
Albania
1
Timor Leste/ East Timor
1
Estonia
1
Romania
1
Moldova
1
Kazakhstan
1
Turkmenistan
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
138
Clinical Guidelines
40
Public Health
10
Capacity Building
7
Key Resources
4
Pharmacy & Technologies
4
Women & Child Health
1
Toolboxes
TB
258
HIV
28
AMR
18
Polio
9
Refugee
6
Ebola & Marburg
3
Pharmacy
3
NTDs
3
Caregiver
2
Disability
1
Rapid Response
1
Specific Hazards
1
COVID-19
1
2.0 Rapid Response
1
Tuberculosis MDR-TB & XDR-TB The 2008 Report
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- an
...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-
...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB
...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la
...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD ...
The term "Programmatic Management of Drug Resistant TB" (PMD ...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...
Le présent manuel fournit les directives actualisées à l'intention des médecins, infirmiers et laborantins confrontés à la tuberculose multirésistante (TB-MR). Il remplace la version élaborée en 2007 et s’est enrichi de l’expérience pratique de six années. Il s’appuie sur les recomm
...
Antimicrobial Resistance and Infection Control 2014,3 :31
Lignes directrices.
Collection Avis et Rapports.
3rd edition
факты о легких и туберкулезе - информационная брошюра ; первая часть
(Туберкулез с множественной лекарственной устойчивостью ; вторая часть)
Accessed on September 2019
